GGrantIndex
← Leaderboards

Veronica Shubayev

University Of California, San Diego

$5,703,515
Attributed
$8,109,132
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $787.8K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,109,132 · 3
VA$0 · 1

By mechanism

R01$7,278,782 · 1
R21$830,350 · 2
I01$0 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsProgramsNerve InjuryNervePainful NeuropathyInjuryMediatingImmunePainMyelinCellsSciatic NerveSignal TransductionNeuroinflammationMolecularMatrix MetalloproteinasesInnovationBasePreventAnalgesicsChronic PainSensoryMacrophageBehavioral

Grant awards (28)

Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1$0
I01 · FY2025 · VA · contact PI
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)$0
I01 · FY2023 · VA · contact PI
Myelin Autoantigens in Neuropathic Pain$746,995
R01 · FY2022 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)$0
I01 · FY2022 · VA · contact PI
Myelin Autoantigens in Neuropathic Pain$720,999
R01 · FY2021 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)$0
I01 · FY2021 · VA · contact PI
Myelin Autoantigens in Neuropathic Pain$719,586
R01 · FY2020 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)$0
I01 · FY2020 · VA · contact PI
Myelin Autoantigens in Neuropathic Pain$723,170
R01 · FY2019 · DE · contact PI
Myelin Autoantigens in Neuropathic Pain$759,606
R01 · FY2018 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2018 · VA · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2017 · VA · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$687,775
R01 · FY2016 · DE · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$100,000
R01 · FY2016 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2016 · VA · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$693,414
R01 · FY2015 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2015 · VA · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$696,603
R01 · FY2014 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2014 · VA · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$670,052
R01 · FY2013 · DE · contact PI
Proteolysis of Myelin as a Source of Neuropathic Pain$760,582
R01 · FY2012 · DE · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2012 · VA · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2011 · VA · contact PI
Neurotoxicity of Magnetic Nanoparticles$182,208
R21 · FY2010 · ES · contact PI
Neurotoxicity of Magnetic Nanoparticles$223,267
R21 · FY2009 · ES · contact PI
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases$0
I01 · FY2009 · VA · contact PI
Matrix metalloproteinases as biomarkers of neurodegeneration$193,125
R21 · FY2008 · NS · contact PI
Matrix metalloproteinases as biomarkers of neurodegeneration$231,750
R21 · FY2007 · NS · contact PI